Quantum Biopharma (0K91) Financial Statements

0 Followers

Quantum Biopharma Financial Overview

Quantum Biopharma's market cap is currently €16.87M. The company's EPS TTM is €-5.65; its P/E ratio is -0.41; Quantum Biopharma is scheduled to report earnings on August 13, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Mar 22
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -15.30M	$ -16.14M	$ -23.79M	$ -27.43M	$ -33.74M
EBITDA	$ -25.79M	$ -14.38M	$ -15.72M	$ -22.12M	$ -29.82M
Net Income	$ -26.18M	$ -14.20M	$ -17.90M	$ -23.61M	$ -35.29M
Balance Sheet
Cash & Short-Term Investments	$ 6.17M	$ 7.20M	$ 3.51M	$ 17.00M	$ 35.42M
Total Assets	$ 11.14M	$ 17.12M	$ 17.47M	$ 38.41M	$ 62.96M
Total Debt	$ 1.87M	$ 824.92K	$ 339.20K	$ 516.42K	$ 555.90K
Net Debt	$ -29.09K	$ -5.17M	$ -2.42M	$ -16.46M	$ -34.70M
Total Liabilities	$ 6.05M	$ 6.68M	$ 4.57M	$ 7.87M	$ 8.83M
Stockholders' Equity	$ 6.91M	$ 11.48M	$ 13.24M	$ 30.54M	$ 54.13M
Cash Flow
Free Cash Flow	$ -8.38M	$ -6.88M	$ -10.83M	$ -28.70M	$ -21.25M
Operating Cash Flow	$ -8.38M	$ -6.88M	$ -10.83M	$ -28.33M	$ -20.75M
Investing Cash Flow	$ -1.99M	$ -1.50M	$ -269.58K	$ 12.12M	$ 268.96K
Financing Cash Flow	$ 6.21M	$ 11.62M	$ -3.13M	$ -2.07M	$ 38.21M

Quantum Biopharma Earnings and Revenue History

Income Statement >

Quantum Biopharma Debt to Assets

Balance Sheet >

Quantum Biopharma Cash Flow

Cash Flow >

Quantum Biopharma Forecast EPS vs Actual EPS

Earnings >